Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 03/02/2011
PIL Androcur

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 31/01/2011 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Extra statutory information
Updated on 17/06/2010 and displayed until 31/01/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/06/2010 and displayed until 17/06/2010
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to date of revision
Updated on 10/09/2009 and displayed until 09/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 17/08/2009 and displayed until 10/09/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 04/06/2008 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of licence holder
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 22/09/2006 and displayed until 04/06/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 03/09/2004 and displayed until 22/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/08/2004 and displayed until 03/09/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 15/07/2002 and displayed until 31/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 24/07/2001 and displayed until 15/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 19/07/2000 and displayed until 24/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   cyproterone acetate